Beth Beghou and Patrick Lezark on how emerging pharma can use advanced analytics to improve commercial operations

Share on facebook
Share on twitter
Share on linkedin

The 2019 Emerging Pharma Pulse Report found that nearly 60% of emerging pharma companies only use advanced analytics “somewhat” or “to a limited extent” to generate commercial insights. Managing Director Beth Beghou and Partner Patrick Lezark share with Pharmaceutical Executive how emerging pharma companies can implement an advanced analytics to improve all facets of commercial operations.